Suppression of PTEN Expression by NF-κB Prevents Apoptosis

Molecular and Cellular Biology

Volumn 24, Issue 3, 2004, Pages 1007-1021

  Vasudevan, Krishna Murthi ^a   Gurumurthy, Sushma ^a   Rangnekar, Vivek M ^a,b,c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; SYNAPTOTAGMIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL STRAIN 3T3; CELL SURVIVAL; GENE REPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; APOPTOSIS; CREB-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HUMANS; MICE; NF-KAPPA B; NIH 3T3 CELLS; NUCLEAR PROTEINS; PHOSPHORIC MONOESTER HYDROLASES; PROMOTER REGIONS (GENETICS); PTEN PHOSPHOHYDROLASE; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR RELA; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA;

EID: 1642499403     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.3.1007-1021.2004     Document Type: Article

References (60)

1. Alcamo, E., J. P. Mizgerd, B. H. Horwitz, R. Bronson, A. A. Beg, M. Scott, C. M. Doerschuk, R. O. Hynes, and D. Baltimore. 2001. Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-kappa B in leukocyte recruitment. J. Immunol. 167:1592-1600.
2. Beg, A. A., and D. Baltimore. 1996. An essential role for NF-kappa B in preventing TNF-alpha-induced cell death. Science 274:782-784.
3. Beg, A. A., W. C. Sha, R. T. Brunson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mite lacking the RelA component of NF-kappa B. Nature 376:167-170.
4. Brognard, J., A. S. Clark, Y. Ni, and P. A. Dennis. 2001. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res. 61:3986-3997.
5. Chakraborty, M., S. G. Qiu, K. M. Vasudevan, and V. M. Rangnekar. 2001. Par-4 drives trafficking and activation of Fas and Fas1 to induce prostate cancer cell apoptosis and tumor regression. Cancer Res. 61:7255-7263.
6. Chan, H. M., and N. B. La Thangue. 2001. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell Sci. 114:2363-2373.
7. Chen, T. C., D. R. Hinton, R. Zidovetzki, and F. M. Hofman. 1998. Upregulation of the cAMP/PKA pathway inhibits proliferation, induces differentiation, and leads to apoptosis in malignant gliomas. Lab. Investig. 78:165-174.
8. Chin, K. V., W. L. Yang, R. Ravatn, T. Kita, E. Reitman, D. Vettori, M. E. Cvijic, M. Shin, and L. Iacono. 2002. Reinventing the wheel of cyclic AMP: novel mechanisms of cAMP signaling. Ann. N. Y. Acad. Sci. 968:49-64.
9. Chrivia, J. C., R. P. Kwok, N. Lamb, M. Hagiwara, M. R. Montminy, and R. H. Goodman. 1993. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365:855-859.
10. Di Cristofano, A., P. Kotsi, Y. F. Peng, C. Cordun-Cardo, K. B. Elkun, and P. P. Pandolti. 1999. Impaired Fas response and autoimmunity in Pten+/-mice. Sciente 285:2122-2125.
11. Di Cristofano, A., and P. P. Pandolfi. 2000. The multiple roles of PTEN in tumor suppression. Cell 100:387-390.
12. Di Cristofano, A., B. Pesce, C. Cordon-Cardo, and P. P. Pandolfi. 1998. Pten is essential for embryonic development and tumour suppression. Nat. Genet. 19:348-355.
13. Eckner, R., M. E. Ewen, D. Newsome, M. Gerdes, J. A. DeCaprio, J. B. Lawrence, and D. M. Livingston. 1994. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8:869-884.
14. Frisk, T., T. Foukakis, T. Dwight, J. Lundberg, A. Hoog, G. Wallin, C. Eng, J. Zedenius, and C. Larsson. 2002. Silencing of the PTEN mmor-suppressor gene in anaplastic thyroid cancer. Genes Chromosomes Cancer 35:74-80.
15. Fujita, N., S. Sato, K. Katayama, and T. Tsuruo. 2002. Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization. J. Biol. Chem. 277:287116-28713.
16. Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-kappaB puzzle. Cell 109(Suppl.):S81-S96.
17. Goodman, R. H., and S. Smolik. 2000. CBP/p300 in cell growth, transformation, and development. Genes Dev. 14:1553-1577.
18. Hanahan, D., and R. A. Weinberg. 2000. The hallmarks of cancer. Cell 100:57-70.
19. Hofer-Warbinek, R., J. A. Scbmid, C. Stehlik, B. R. Binder, J. Lipp, and R. de Martin. 2000. Activation of NF-kappa B by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAKI. J. Biol. Chem. 275:22064-22068.
20. Hoffmann, A., A. Levchenko, M. L. Scutt, and D. Baltimore. 2002. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 298:1241-1245.
21. Horvai, A. E., L. Xu, E. Korzus, G. Brard, D. Kalafus, T. M. Mullen, D. W. Ruse, M. G. Rosenfeld, and C. K. Glass. 1997. Nuclear integration of JAK/ STAT and Ras/AP-I signaling by CBP and p300. Proc. Natl. Acad. Sci. USA 94:1074-1079.
22. Hottiger, M. O., and G. J. Nabel. 1998. Interaction of human immunodeficiency virus type I Tat with the transcriptional coactivators 17300 and CREB binding protein. J. Virol. 72:8252-8256.
23. Hsu, A. L., T. T. Ching, D. S. Wang, X. Song, V. M. Rangnekar, and C. S. Chen. 2000. The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. J. Biol. Chem. 275:11397-11403.
24. Kamei, Y., L. Xu, T. Heinzel, J. Torchia, R. Kurokawa, B. Gloss, S. C. Lin, R. A. Heyman, D. W. Rose, C. K. Glass, and M. G. Rosenfeld. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414.
25. Karin, M., Y. Cao, F. R. Greten, and Z. W. Li. 2002. NF-kappaB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2:301-310.
26. Karin, M., and A. Lin. 2002. NF-kappaB at the crossroads of life and death. Nat. Immunol. 3:221-227.
27. Li, Q., D. Van Antwerp, F. Mercurio, K. F. Lee, and I. M. Verma. 1999. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 284:321-325.
28. Li, Z. W., W. Chu, Y. Hu, M. Delhase, T. Deerinck, M. Ellisman, R. Johnson, and M. Karin. 1999. The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J. Exp. Med. 189:1839-1845.
29. Liliental, J., S. Y. Moon, R. Lesche, R. Mamillapalli, D. Li, Y. Zheng, H. Sun, and H. Wu. 2000. Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases. Curr. Biol. 10:401-404.
30. Madrid, L. V., M. W. Mayo, J. Y. Reuther, and A. S. Baldwin, Jr. 2001. Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J. Biol. Chem. 276:18934-18940.
31. Madrid, L. V., C. Y. Wang, D. C. Guttridge, A. J. Schottelius, A. S. Baldwin, Jr., and M. W. Mayo. 2000. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol. Cell. Biol. 20:1626-1638.
32. Marsh, D. J., P. L. Dahia, Z. Zheng, D. Liaw, R. Parsons, R. J. Gorlin, and C. Eng. 1997. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat. Genet. 16:333-334.
33. Mayo, M. W., L. V. Madrid, S. D. Westerheide, D. R. Jones, X. J. Yuan, A. S. Baldwin, Jr., and Y. E. Whang. 2002. PTEN blocks tumor necrosis factor induced NF-kappa B-dependent transcription by inhibiting the transactivation potential of the p65 subunit. J. Biol. Chem. 277:11116-11125.
34. Nakamura, N., S. Ramaswamy, F. Vazquez, S. Signoretti, M. Loda, and W. R. Sellers. 2000. Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol. Cell. Biol. 20: 8969-8982.
35. Nalca, A., S. G. Qiu, N. El-Guendy, S. Krishnan, and V. M. Rangnekar. 1999. Oncogenic Ras sensitizes cells to apoptosis by Par-4. J. Biol. Chem. 274: 29976-29983.
36. Nicot, C., and R. Harrod. 2000. Distinct p300-responsive mechanisms promote caspase-dependent apoptosis by human T-cell lymphotropic virus type 1 Tax protein. Mol. Cell. Biol. 211:8580-8589.
37. Nicot, C., R. Mahieux, C. Pise-Masison, J. Brady, A. Gessain, S. Yamaoka, and G. Franchini. 2001. Human T-cell lymphotropic virus type 1 Tax represses c-Myb-dependent transcription through activation of the NF-κB pathway and modulation of coactivator usage. Mol. Cell. Biol. 21:7391-7402.
38. Okazaki, T., S. Sakon, T. Sasazuki, H. Sakurai, T. Dui, H. Yagita, K. Okumura, and H. Nakano. 2003. Phosphorylation of serine 276 is essential for p65 NF-kappaB subunit-dependent cellular responses. Biochem. Biophys. Res. Commun. 300:807-812.
39. Qiu, S. G., S. Krishnan, N. el-Guendy, and V. M. Rangnekar. 1999. Negative regulation of Par-4 by oncogenic Ras is essential for cellular transformation. Oncogene 18:7115-7123.
40. Sheppard, K. A., K. M. Phelps, A. J. Williams, D. Thanos, C. K. Glass, M. G. Rosenfeld, M. E. Gerritsen, and T. Collins. 1998. Nuclear integration of glucocorticoid receptor and nuclear factor-kappaB signaling by CREB-binding protein and steroid receptor coactivator-1. J. Biol. Chem. 273:29291-29294.
41. Simpson, L., and R. Parsons. 2001. PTEN: life as a tumor suppressor. Exp. Cell Res. 264:29-41.
42. Stambolic, V., D. MacPherson, D. Sas, Y. Lin, B. Snow, Y. Jang, S. Benchimol, and T. W. Mak. 2001. Regulation of PTEN transcription by p53. Mol. Cell 8:317-325.
43. Stambolic, V., A. Suzuki, J. L. de la Pompa, G. M. Brothers, C. Mirtsos, T. Sasaki, J. Ruland, J. M. Penninger, D. P. Siderovski, and T. W. Mak. 1998. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95:29-39.
44. Stehlik, C., R. de Martin, I. Kamabashiri, J. A. Schmid, B. R. Binder, and J. Lipp. 1998. Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J. Exp. Med. 188:211-216.
45. Tamura, M., J. Gu, K. Matsumuto, S. Aota, R. Parsons, and K. M. Yamada. 1998. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280:1614-1617.
46. Tang, G., J. Yang, Y. Minemoto, and A. Lin. 2001. Blocking caspase-3-mediated proteolysis of IKKbeta suppresses TNF-alpha-induced apoptosis. Mol. Cell 8:1005-1016.
47. Virolle, T., E. D. Adamson, V. Baron, D. Birle, D. Mercola, T. Mustelin, and I. de Belle. 2001. The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling. Nat. Cell Biol. 3:1124-1128.
48. Wadgaonkar, R., K. M. Phelps, Z. Haque, A. J. Williams, E. S. Silverman, and T. Collins. 1999. CREB-binding protein is a nuclear integrator of nuclear factor-kappaB and p53 signaling. J. Biol. Chem. 274:1879-1882.
49. Waltner-Law, M., M. C. Daniels, C. Sutherland, and D. K. Granner. 2000. NF-kappa B inhibits glucocorticoid and cAMP-mediated expression of the phosphoenolpyruvate carboxykinase gene. J. Biol. Chem. 275:31847-31856.
50. Wung, C. Y., J. C. Cusack Jr., R. Liu, and A. S. Baldwin, Jr. 1999. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nat. Med. 5:412-417.
51. Wang, C. Y., M. W. Mayu, and A. S. Baldwin, Jr. 1996. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274:784-787.
52. Wang, C. Y., M. W. Mayo, R. G. Korneluk, D. V. Goeddel, and A. S. Baldwin, Jr. 1998. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP2 and c-IAP2 to suppress caspase-8 activation. Science 281:16811-1683.
53. Wang, S. I., R. Parsons, and M. Ittmann. 1998. Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas. Clin. Cancer Res. 4:811-815.
54. Webster, G. A., and N. D. Perkins. 1999. Transcriptional cross talk between NF-κB and p53. Mol. Cell. Biol. 19:3485-3495.
55. Weng, L. P., O. Gimm, J. B. Kum, W. M. Smith, X. P. Zhou, D. Wynford-Thomas, G. Leone, and C. Eng. 2001. Transient ectopic expression of PTEN in thyroid cancer cell lines induces cell cycle arrest and cell type-dependent cell death. Hum. Mol. Genet. 10:251-258.
56. Yokomizo, A., D. J. Tindall, H. Drabkin, R. Gemmill, W. Franklin, P. Yang, K. Sugio, D. I. Smith, and W. Liu. 1998. PTEN/MMACI mutations identified in small cell, but not in non-small cell lung cancers. Oncogene 17:475-479.
57. Zhong, H., H. SuYang, H. Erdjument-Bromage, P. Tempst, and S. Ghosh. 1997. The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89:413-424.
58. Zhong, H., R. E. Voll, and S. Ghosh. 1998. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell 1:661-671.
59. Zhou, B. P., Y. Liao, W. Xia, Y. Zou, B. Spohn, and M. C. Hung, 2001. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat. Cell Biol. 3:973-982.
60. Zysman, M. A., W. B. Chapman, and B. Bapat. 2002. Considerations when analyzing the methylation status of PTEN tumor suppressor gene. Am. J. Pathol. 160:795-800.